GL1X · GenesisL1 explorer

Research workbench

Human NBD1 of cftr in complex with nanobodies T2A and T4

Analyse Human NBD1 of cftr in complex with nanobodies T2A and T4 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6GJU
Type
protein
Length
421 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cystic fibrosis transmembrane conductance regulator; Nanobody T4; Nanobody T2A
EC
3.6.3.49
UniProt
Q20BJ8
Pockets
6 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACystic fibrosis transmembrane conductance regulator (EC 3.6.3.49)protein18340% helix, 19% strandQ20BJ8
BNanobody T4protein1185% helix, 62% strand—
CNanobody T2Aprotein1203% helix, 61% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12750.680.8439empty
24070.670.8057empty
31400.410.7522empty
4740.400.7914empty
5900.350.7517empty

Interfaces

3 interfaces between chains.

  • A–B · 994 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 765 Ų buried · 5 hydrogen bonds · protein-protein
  • B–C · 39 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6GJU · human NBD1 of CFTR in complex with nanobodies T2a and T4 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.